Skip to content
WeighLab
Menu
Ranked #509 · Grade C

AM Rx review

AM Rx (getamrx.com) is a telehealth platform operated by FitRX.

Visit AM Rx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$297/mo (all doses, bundle, plus a separate fee, compounded)
Tirzepatide
$449/mo (all doses, bundle, compounded)
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · modeled / year

$3,564

Tirzepatide · modeled / year

$5,388

Pricing verified August 2026

The Index scorecard

AM Rx scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month40/100
Price Transparency46/100
Nationwide Access24/100
Formulation Options79/100
Clinical Oversight41/100
Contract Flexibility20/100

Where the value is

  • Insurance coordination for brand-name Ozempic/Wegovy/Zepbound/Mounjaro, quoting copays 'as little as $25 per month'
  • A flat 'Bundle' pricing option ($297 semaglutide / $449 tirzepatide after a discounted first month) avoids the ambiguity of the a-la-carte route's undisclosed ongoing membership fee
  • HSA/FSA accepted
  • Same operational backing as RoenRx (FitRX, LLC / Zealthy), so the underlying provider network and compliance posture is shared with a sibling platform that has more transparent membership disclosure

The tradeoffs

  • The headline 'starting as low as $151/$216 per month' figures require a separate ongoing membership fee that AM Rx's own FAQ never discloses the amount of — unlike sibling site RoenRx, which explicitly states $135/month for the equivalent membership
  • No states list is published; the only geographic restriction disclosed is exclusion of government-insurance (Medicare/Medicaid) patients
  • No compounding pharmacy or medical director is named anywhere on the site
  • Parent company Zealthy connection carries previously documented regulatory and reputational concerns (BBB rating, FTC/DOJ scrutiny) that I did not re-verify live this session — confirm current status before relying on it
  • FDA issued FitRX, LLC dba AM RX a warning letter in June 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: Cost-first shoppers who want insured shoppers chasing brand-name GLP-1 copays, provided they choose the flat Bundle plan rather than the a-la-carte route whose true monthly cost the site doesn't fully disclose. AM Rx (getamrx.com) is a telehealth platform operated by FitRX.

Ranked #509 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to AM Rx.

The 18 programs nearest this one

Pricing, states and verification reflect AM Rx's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on AM Rx's site. Not medical advice; see our disclosure.

← Back to the value leaderboard